Edison P, Walker Z, Coulthard E, Hlscher C, Passmore A, Ballard C
Updated multi-society guidance now suggests that most patients can continue GLP-1 therapy before elective procedures, including those involving anesthesia, with individualized assessment for delayed gastric emptying in patients undergoing dose-escalation phase or with significant gastrointestinal symptoms
Roles of glutathione (GSH) in dopamine (DA) oxidation studied by improved tandem HPLC plus ESI-MS
L-carnitine supplementation reduced the levels of ammonia in patients with cirrhosis with physiological blood carnitine levels (34), suggesting that increased quantities of carnitine is required for patients with cirrhosis compared with the healthy individuals, and that patients may have exhibited a relative carnitine deficiency
To help preserve muscle while on GLP-1 medications, focus on eating enough protein and making strength training part of your regular routine
Research continues into non-alcoholic fatty liver disease/NASH, dyslipidaemia, insulin resistance, and cardiovascular risk reduction
